The Efficacy and Safety of Tolvaptan in Heart Failure Patients with Congestive Signs: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Objective:. The aim of this study was to investigate the efficacy and safety of tolvaptan, as well as the impact of its treatment dose and duration in heart failure patients with congestive signs. Methods:. The PubMed, Embase, Cochrane Library, and ClinicalTrials.gov databases were searched to colle...
Saved in:
| Main Authors: | Mei Zeng, Na Li, Tongshuai Chen, Yun Ti, Chunmei Zhang, Peili Bu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2023-03-01
|
| Series: | Cardiology Discovery |
| Online Access: | http://journals.lww.com/10.1097/CD9.0000000000000061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis.
by: Mei-Yi Wu, et al.
Published: (2017-01-01) -
Factors associated with readmission after long-term administration of tolvaptan in patients with congestive heart failure
by: Shoko Yamashita, et al.
Published: (2024-11-01) -
Deer Horn Sign in Congestive Hepatopathy Due to Heart Failure
by: Thomas Ferenc, et al.
Published: (2025-05-01) -
Signs of congestion, quality of life and short‐term rehospitalization in patients with heart failure
by: Geert H.D. Voordes, et al.
Published: (2025-08-01) -
Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
by: Shunsuke Kiuchi, et al.
Published: (2021-12-01)